Associação Hospital de Caridade Ijuí

Ijuí 98700-000

0 studies enrolling now · 3 studies all time

What they study most

Hepatocellular Carcinoma, Non Small Cell Lung Cancer, Ovarian Cancer

Studies at this site

• A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer — Running, not enrolling
• A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-Fetoprotein — Completed
• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early